Hunan Jiudian Pharmaceutical Co., Ltd.
Hunan Jiudian Pharmaceutical Co., Ltd., commonly referred to as Jiudian Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical products, primarily focusing on innovative drug formulations and active pharmaceutical ingredients (APIs). With a strong operational presence across various regions in China, Jiudian Pharmaceutical is renowned for its commitment to research and development, which has led to the successful launch of several unique products. The company’s core offerings include a diverse range of prescription medications and over-the-counter solutions, distinguished by their efficacy and safety profiles. Recognised for its robust market position, Hunan Jiudian Pharmaceutical has achieved notable milestones, including certifications from international regulatory bodies, underscoring its dedication to quality and compliance in the pharmaceutical sector.
DitchCarbon Score
How does Hunan Jiudian Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hunan Jiudian Pharmaceutical Co., Ltd.'s score of 37 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hunan Jiudian Pharmaceutical Co., Ltd.'s reported carbon emissions
In 2023, Hunan Jiudian Pharmaceutical Co., Ltd. reported total carbon emissions of approximately 12,268,800 kg CO2e from Scope 2, 7,139,500 kg CO2e from Scope 1, and 1,076,000 kg CO2e from Scope 3. This reflects a notable increase in emissions compared to previous years, with 2022 emissions recorded at about 8,957,800 kg CO2e for Scope 2, 5,508,300 kg CO2e for Scope 1, and 553,100 kg CO2e for Scope 3. The company has not disclosed any specific reduction targets or initiatives, indicating a lack of formal commitments to reduce carbon emissions at this time. However, the data suggests a need for enhanced climate strategies to address the rising emissions trend. Hunan Jiudian Pharmaceutical operates within a critical industry context, where effective climate action is essential for sustainability and compliance with global environmental standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 5,710,200 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 8,439,400 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 765,700 | 000,000 | 0,000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hunan Jiudian Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
